BioCentury
ARTICLE | Financial News

Newco Codiak launched

November 18, 2015 2:02 AM UTC

Codiak BioSciences Inc. (Cambridge, Mass.) made its debut Tuesday with the first tranche of a planned $80 million combined series A and B financing led by Flagship Ventures and Arch Venture Partners. Douglas Williams, former head of R&D at Biogen Inc. (NASDAQ:BIIB), is Codiak's president and CEO.

Other investors included Fidelity Management & Research, Alaska Permanent Fund and Alexandria Venture Investments. Details of the series A and B rounds are undisclosed. ...



Access The Full Article